Domov › Akutna mieločna levkemija › Utah › Salt Lake City
Klinične študije za Akutna mieločna levkemija v Salt Lake City, UT
17 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Salt Lake City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Ivosidenib as Post-HSCT Maintenance for AML
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- Intermountain Healthcare LDS Hospital, Salt Lake City
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Vključevanje udeležencevFaza 3
- Primary Children's Hospital, Salt Lake City
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute, Salt Lake City
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Vključevanje udeležencevFaza 2
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Vključevanje udeležencevFaza 1/2
- Primary Children's Hospital, Salt Lake City
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Vključevanje udeležencevFaza 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- Primary Children's Hospital, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Vključevanje udeležencevOpazovalna študija
- University of Utah, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Vključevanje udeležencevFaza 1
- University of Utah, Salt Lake City
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Vključevanje udeležencevFaza 1
- University of Utah, Salt Lake City
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Vključevanje udeležencevFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Študije za Akutna mieločna levkemija v drugih mestih
- Houston, TX85 študij
- New York City, NY51 študij
- Boston, MA44 študij
- Seattle, WA41 študij
- Baldwin Park, CA40 študij
- Columbus, OH35 študij
- Philadelphia, PA34 študij
- Durham, NC33 študij
- Atlanta, GA31 študij
- Tampa, FL29 študij
- Chicago, IL26 študij
- Portland, OR25 študij
Druge študije v Salt Lake City
- Nemalicelični pljučni rak31 študij
- Rak (vse vrste)27 študij
- Rak dojke27 študij
- Kolorektalni rak22 študij
- Rak pljuč21 študij
- Melanom21 študij
- Množni mielom21 študij
- Metastatski rak20 študij
- Rak jajčnikov19 študij
- Debelost18 študij
- Srčno popuščanje17 študij
- Rak prostate15 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.